{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:24:03Z","timestamp":1782793443635,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-026-00630-2","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:56:34Z","timestamp":1771944994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of IV cyclophosphamide and mycophenolate mofetil in the treatment of childhood-onset lupus nephritis in a resource-limited setting"],"prefix":"10.1186","volume":"10","author":[{"given":"Adrienne Katrin M.","family":"Guiang-Valerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma. Theresa M.","family":"Collante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"4","key":"630_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/jcm10040559","volume":"10","author":"SP Tang","year":"2021","unstructured":"Tang SP, Lim SC, Arkachaisri T. Childhood-Onset Systemic Lupus Erythematosus: Southeast Asian Perspectives. J Clin Med. 2021;10(4):559. https:\/\/doi.org\/10.3390\/jcm10040559. PMID: 33546120; PMCID: PMC7913223.","journal-title":"J Clin Med"},{"key":"630_CR2","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, et al. Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum. 2012;64:2677\u201386. https:\/\/doi.org\/10.1002\/art.34473.","journal-title":"Arthritis Rheum"},{"key":"630_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.rdc.2009.12.012","volume":"36","author":"R Mina","year":"2010","unstructured":"Mina R, Brunner HI. Pediatric lupus\u2014Are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin N Am. 2010;36:53\u201380.","journal-title":"Rheum Dis Clin N Am"},{"key":"630_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15\u201329.","journal-title":"Ann Rheum Dis"},{"key":"630_CR5","doi-asserted-by":"publisher","unstructured":"De Mutiis C, Wenderfer SE, Orjuela A, Bagga A, Basu B, Sar T, Aggarwal A, Jain A, Yap HK, Ito S, Ohnishi A, Iwata N, Kasapcopur O, Laurent A, Mastrangelo A, Ogura M, Shima Y, Rianthavorn P, Silva CA, Trindade V, Dormi A, Tullus K. Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. Rheumatology (Oxford). 2022;61(6):2563\u20132571. https:\/\/doi.org\/10.1093\/rheumatology\/keab746. PMID: 34626102.","DOI":"10.1093\/rheumatology\/keab746"},{"issue":"1","key":"630_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","volume":"8","author":"EY Chan","year":"2022","unstructured":"Chan EY, Yap DY, Wong WT, Wong WH, Wong SW, Lin KY, Hui FY, Yee-Ming J, Lam SS, Wong JK, Lai FF, Ho TW, Tong PC, Lai WM, Chan TM, Ma AL. Long-Term Outcomes of Children and Adolescents With Biopsy-Proven Childhood-Onset Lupus Nephritis. Kidney Int Rep. 2022;8(1):141\u201350. https:\/\/doi.org\/10.1016\/j.ekir.2022.10.014. PMID: 36644360; PMCID: PMC9831948.","journal-title":"Kidney Int Rep"},{"key":"630_CR7","doi-asserted-by":"publisher","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstr\u00f8m K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirj\u00e1k L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kum\u00e1novics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, R\u00faa-Figueroa Fern\u00e1ndez \u00cd, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, D\u00f6rner T, Johnson SR. 2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930. Epub 2019 Aug 6. PMID: 31385462; PMCID: PMC6827566.","DOI":"10.1002\/art.40930"},{"key":"630_CR8","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group. KDIGO 2024 clinical practice guideline for the management of lupus nephritis. Kidney Int. 2024;105(1S):S1-S69. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002. PMID: 38182286.","DOI":"10.1016\/j.kint.2023.09.002"},{"issue":"3","key":"630_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40620-022-01438-2","volume":"36","author":"M Chbihi","year":"2023","unstructured":"Chbihi M, Eveillard LA, Riller Q, Brousse R, Berthaud R, Quartier P, Salomon R, Charbit M, Avramescu M, Biebuyck N, Dehoux L, Garcelon N, Duong-Van-Huyen JP, Bader-Meunier B, Boyer O. Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide. J Nephrol. 2023;36(3):829\u201339. https:\/\/doi.org\/10.1007\/s40620-022-01438-2. Epub 2022 Oct 8. PMID: 36208405.","journal-title":"J Nephrol"},{"issue":"11","key":"630_CR10","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s00467-023-06018-5","volume":"38","author":"C De Mutiis","year":"2023","unstructured":"De Mutiis C, Wenderfer SE, Basu B, Bagga A, Orjuela A, Sar T, Aggarwal A, Jain A, Yap HK, Teo S, Ito S, Ohnishi A, Iwata N, Kasapcopur O, Yildiz M, Laurent A, Mastrangelo A, Ogura M, Shima Y, Rianthavorn P, Silva CA, Trindade V, Gianviti A, Akinori M, Hamada R, Fujimura J, Minamikawa S, Kamiyoshi N, Kaito H, Ishimori S, Iannuzzella F, Tullus K. International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24 months. Pediatr Nephrol. 2023;38(11):3699\u2013709. https:\/\/doi.org\/10.1007\/s00467-023-06018-5. Epub 2023 May 24. PMID: 37221349.","journal-title":"Pediatr Nephrol"},{"key":"630_CR11","doi-asserted-by":"publisher","unstructured":"Chan EY, Yap DY, Wong WH, Wong SW, Lin KY, Hui FY, Li JY, Lam SS, Wong JK, Lai FF, Ho TW, Tong PC, Lai WM, Chan TM, Ma AL. Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study. Rheumatology (Oxford). 2024;63(4):953\u2013961. https:\/\/doi.org\/10.1093\/rheumatology\/kead447. PMID: 37632777.","DOI":"10.1093\/rheumatology\/kead447"},{"key":"630_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00467-021-05164-y","volume":"37","author":"S Qiu","year":"2022","unstructured":"Qiu S, Zhang H, Yu S, et al. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis. Pediatr Nephrol. 2022;37:367\u201376. https:\/\/doi.org\/10.1007\/s00467-021-05164-y.","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"630_CR13","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1177\/09612033231202843","volume":"32","author":"D Biswas","year":"2023","unstructured":"Biswas D, Dasgupta D, Pal P, Sinha R. Presentation and outcome of pediatric lupus nephritis from a large single centre contemporary cohort in Eastern India. Lupus. 2023;32(12):1440\u20136. Epub 2023 Sep 14. PMID: 37707867.","journal-title":"Lupus"},{"issue":"6","key":"630_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41390-023-02747-3","volume":"94","author":"X Zheng","year":"2023","unstructured":"Zheng X, Ouyang X, Cheng C, Rong L, Chen L, Mo Y, Jiang X. Efficacy and safety of multi-target therapy in children with lupus nephritis. Pediatr Res. 2023;94(6):2040\u20136. https:\/\/doi.org\/10.1038\/s41390-023-02747-3. Epub 2023 Jul 24. PMID: 37488301.","journal-title":"Pediatr Res"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00630-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00630-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00630-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:32:01Z","timestamp":1773883921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00630-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00630-2","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was submitted to the Research Ethics Committee of the University of Santo Tomas Hospital (USTH-REC) and was given approval with protocol reference number REC-2024-10-142-TF-FR-AP. This study was done in compliance with the ethical principles set by the World Medical Association (WMA) in the Declaration of Helsinki (2013), the WHO Operational Guidelines, the National Ethical Guidelines for Research Involving Human Participants 2022 (NEGRHIP 2022) and the ICH - Good Clinical Practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}